Inspired Breathing Webinar: A New Era in Airways Disease: Type 2 Inflammation and Biologics
Join us on Wednesday, September 23rd at 12:00 pm (CST/SK), for an Inspired Breathing Webinar.
This Inspired Breathing webinar will explore how the understanding and treatment of airways disease is evolving beyond traditional bronchodilator-based approaches. Presented by our key opinion leader Dr. Melissa Morgunov, this session will examine the growing role of Type 2 inflammation in asthma, COPD, and nasal polyps, including key clinical features and biomarkers that may support treatment escalation or specialist referral. Participants will also explore the expanding role of biologic therapies as part of a personalized approach to airways disease management.
About our presenter:
Dr. Melissa Morgunov is a Calgary based physician with a special interest in respiratory health and advancing patient centred care in airways disease. With experience in the evolving management of asthma, COPD, and related inflammatory conditions, Dr. Morgunov is passionate about translating emerging evidence into practical clinical care. She is committed to helping healthcare providers better understand emerging therapies and evolving treatment pathways, with a focus on improving outcomes and quality of life for patients living with chronic respiratory disease. Through her clinical work and education initiatives, she supports a collaborative, evidence-informed approach to respiratory care and precision medicine.
This webinar is supported through a Lung Saskatchewan and Sanofi partnership.